STACUL, FULVIO
 Distribuzione geografica
Continente #
NA - Nord America 2.031
EU - Europa 1.809
AS - Asia 1.352
SA - Sud America 207
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 5.461
Nazione #
US - Stati Uniti d'America 1.949
PL - Polonia 679
SG - Singapore 468
IT - Italia 426
CN - Cina 266
BR - Brasile 168
SE - Svezia 157
VN - Vietnam 154
HK - Hong Kong 120
DE - Germania 88
BD - Bangladesh 87
KR - Corea 67
FR - Francia 66
RU - Federazione Russa 62
NL - Olanda 57
IN - India 54
CA - Canada 53
GB - Regno Unito 44
FI - Finlandia 42
BG - Bulgaria 34
IE - Irlanda 29
TR - Turchia 28
UA - Ucraina 27
MA - Marocco 18
AT - Austria 17
ES - Italia 16
CH - Svizzera 15
MX - Messico 14
JP - Giappone 12
AR - Argentina 11
IQ - Iraq 11
SA - Arabia Saudita 11
BE - Belgio 10
ZA - Sudafrica 10
EC - Ecuador 9
PH - Filippine 9
CZ - Repubblica Ceca 8
LT - Lituania 8
PK - Pakistan 8
ID - Indonesia 7
KE - Kenya 7
MY - Malesia 7
AU - Australia 6
JM - Giamaica 6
UZ - Uzbekistan 6
CO - Colombia 5
IL - Israele 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EG - Egitto 4
EU - Europa 4
VE - Venezuela 4
DK - Danimarca 3
DZ - Algeria 3
IR - Iran 3
JO - Giordania 3
KH - Cambogia 3
NO - Norvegia 3
PA - Panama 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AM - Armenia 2
CG - Congo 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BH - Bahrain 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 5.461
Città #
Warsaw 646
Singapore 279
Ashburn 249
Chandler 174
San Jose 146
Hong Kong 116
Fairfield 112
Woodbridge 95
Trieste 79
Ann Arbor 72
Seoul 64
Chicago 54
Santa Clara 54
Beijing 52
Wilmington 51
Hefei 48
Ho Chi Minh City 47
Milan 44
Houston 42
Boardman 40
Cambridge 40
Princeton 40
Los Angeles 39
Seattle 38
Council Bluffs 36
Hanoi 34
Sofia 34
Columbus 30
Jacksonville 29
Munich 29
Lauterbourg 28
Zgierz 27
Dublin 25
Moscow 25
Toronto 25
São Paulo 24
Buffalo 23
Dallas 22
Helsinki 22
Frankfurt am Main 21
Dong Ket 18
New York 18
The Dalles 16
Casablanca 14
London 14
Kocaeli 13
Orem 13
Düsseldorf 11
Izmir 11
Rome 11
Vienna 11
Bern 10
Brussels 10
Phoenix 10
San Diego 10
Amsterdam 9
Brooklyn 9
Dearborn 8
Johannesburg 8
Leverano 8
Redondo Beach 8
Redwood City 8
Turku 8
Atlanta 7
Boston 7
Castelfranco Veneto 7
Chennai 7
Bremen 6
Catania 6
Haiphong 6
Hangzhou 6
Lappeenranta 6
Montreal 6
Nuremberg 6
Philadelphia 6
Poplar 6
Pune 6
Redmond 6
Rio de Janeiro 6
Tashkent 6
Tokyo 6
Denver 5
Guangzhou 5
Kuala Lumpur 5
Manchester 5
Norwalk 5
Pignone 5
Riyadh 5
Venezia 5
Venice 5
Burlington 4
Cairo 4
Da Nang 4
Des Moines 4
Dhaka 4
Fremont 4
Guarulhos 4
Guayaquil 4
Jinan 4
Mexico City 4
Totale 3.508
Nome #
Activity-based cost analysis of contrast-enhanced ultrasonography (CEUS) related to the diagnostic impact in focal liver lesion characterisation 458
Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines 424
Spinal lesions by infectious spondylodiscitis and hepatocellular carcinoma presenting as spinal metastasis in an HIV-HCV co-infected patient 403
Is cryoablation an effective treatment for trifecta outcomes in small renal masses? Long-term results from a multicenter cryotherapy registry 265
A case series of neoplastic seeding after cryoablative treatment for renal masses 255
Oncological outcomes of active surveillance and percutaneous cryoablation of small renal masses are similar at intermediate term follow-up 246
Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines 215
Initial Ablation Ratio Predicts Volume Reduction and Retreatment After 5 Years From Radiofrequency Ablation of Benign Thyroid Nodules 210
Cryoablation of renal tumors: long-term follow-up from a multicenter experience 199
PD51-12 Comparison of mid-term oncological outcomes of active surveillance and percutaneous cryoablation of small renal masses 192
Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines 192
Cryotherapy of Renal Lesions: Enhancement on Contrast-Enhanced Sonography on Postoperative Day 1 Does Not Imply Viable Tissue Persistence 186
Percutaneous cryoablation of a renal cell carcinoma in a transplanted kidney 180
Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian minimally-invasive treatments of the thyroid group 167
Current status and challenges of us-guided radiofrequency ablation of thyroid nodules in the long term: A systematic review 163
Pain Imaging: A Clinical-Radiological Approach to Pain Diagnosis 153
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee 149
Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center 143
Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee Guidelines 143
Residual vital ratio predicts 5-year volume reduction and retreatment after radiofrequency ablation of benign thyroid nodules but not regrowth 140
Needle tract seeding after percutaneous cryoablation of small renal masses; a case series and literature review 137
Hypersensitivity reactions to contrast media: Part 2. Prevention of recurrent hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee 126
Imaging of renal colic 126
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee 122
Contrast media for hysterosalpingography: systematic search and review providing new guidelines by the Contrast Media Safety Committee of the European Society of Urogenital Radiology 113
Waiting times between examinations with intravascularly administered contrast media: a review of contrast media pharmacokinetics and updated ESUR Contrast Media Safety Committee guidelines 108
Radiofrequency Ablation on Autonomously Functioning Thyroid Nodules: A Critical Appraisal and Review of the Literature 107
Imaging of the Kidney and Urinary Tract: Current and Future Trends 96
Safe use of contrast media in myasthenia gravis: systematic review and updated European Society of Urogenital Radiology Contrast Media Safety Committee guidelines 83
Hypersensitivity reactions to contrast media: Part 1. Management of immediate and non-immediate hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee 69
Safety and evidence of CO2 as a vascular contrast agent as an alternative to iodine-based contrast media in vascular procedures: a systematic review by the ESUR Contrast Medium Safety Committee 6
Safety of positive gastrointestinal contrast media. Updated guidelines by the ESUR Contrast Media Safety Committee 3
Totale 5.579
Categoria #
all - tutte 16.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.859


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022327 21 18 40 32 23 22 17 12 31 26 23 62
2022/2023511 43 96 32 71 40 82 10 52 52 4 25 4
2023/2024338 24 18 17 14 26 47 61 54 19 8 25 25
2024/2025874 36 65 91 67 67 73 48 57 114 86 76 94
2025/20262.131 179 91 129 194 181 179 291 97 213 273 151 153
2026/20271 1 0 0 0 0 0 0 0 0 0 0 0
Totale 5.579